PAB - Biotech/Health - FA - Long - Currently progressing second human trials for treatment of multiple myeloma after no side affects reported for first control group. Results of these trials are reported to be released as soon as possible in the January 14 announcement. Currently a 3 billion dollar industry per annum for treatment and PAB have developed a non-invasive screening of the disease and the current trials are testing effectiveness of their product.
Definition of multiple myeloma is "Multiple (plasma cell) myeloma is cancer of the plasma cells in bone marrow. When a person has this disease, too many malignant (cancerous) plasma cells are made. This causes problems including bone disease, anaemia, kidney problems, reduced immunity and infections. There is no cure, but the condition can usually be managed successfully with treatment."
